Form 8-K - Current report:
SEC Accession No. 0001193125-19-295328
Filing Date
2019-11-19
Accepted
2019-11-19 11:34:33
Documents
3
Period of Report
2019-11-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d647471d8k.htm 8-K 21949
2 EX-99.1 d647471dex991.htm EX-99.1 14372
3 GRAPHIC g647471g79l60.jpg GRAPHIC 7239
  Complete submission text file 0001193125-19-295328.txt   47851
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-49908 | Film No.: 191229665
SIC: 2834 Pharmaceutical Preparations